SCHEMBL27915709

SCHEMBL27915709

CCCCn1cnc(-c2ccc(OC)cc2)c1-c1ccc(OC)c(OC)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTGS2 P35354 4/20 0.50
▸ HDAC3 O15379 1/20 0.46
▸ HDAC4 P56524 1/20 0.46
▸ HDAC1 Q13547 1/20 0.46
▸ HDAC7 Q8WUI4 1/20 0.46
▸ HDAC2 Q92769 1/20 0.46
▸ HDAC10 Q969S8 1/20 0.46
▸ HDAC11 Q96DB2 1/20 0.46
▸ HDAC8 Q9BY41 1/20 0.46
▸ HDAC6 Q9UBN7 1/20 0.46
▸ HDAC9 Q9UKV0 1/20 0.46
▸ HDAC5 Q9UQL6 1/20 0.46
▸ PDE10A Q9Y233 1/20 0.46
▸ ALDH1A1 P00352 3/20 0.43
▸ SMN1; SMN2 Q16637 2/20 0.43
▸ MAPT P10636 2/20 0.43
▸ LMNA P02545 2/20 0.43
▸ MAPK1 P28482 1/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.43
▸ TP53 P04637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27915595 0.93 PTGS2 (0.52) PTGS2HDAC3HDAC4HDAC1HDAC7
SCHEMBL28805345 0.92 SMN1; SMN2 (0.42) PTGS2HDAC3HDAC4HDAC1HDAC7
SCHEMBL27934239 0.86 PTGS2 (0.53) PTGS2HDAC3HDAC4HDAC1HDAC7
SCHEMBL27934237 0.84 PTGS2 (0.43) PTGS2HDAC3HDAC4HDAC1HDAC7
SCHEMBL27934250 0.81 PDE10A (0.52) PTGS2PDE10AMAPTL3MBTL1MAPK14
SCHEMBL27820750 0.81 PTGS2 (0.64) PTGS2HDAC3HDAC4HDAC1HDAC7
SCHEMBL27915575 0.80 PTGS2 (0.52) PTGS2PDE10AALDH1A1SMN1; SMN2MAPT
SCHEMBL27934232 0.79 PTGS2 (0.55) PTGS2HDAC3HDAC4HDAC1HDAC7
SCHEMBL27915711 0.78 PTGS2 (0.42) PTGS2HDAC3HDAC4HDAC1HDAC7
SCHEMBL30023059 0.78 PTGS2 (0.68) PTGS2HDAC3HDAC4HDAC1HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102190625-B Stilbene tumor targeted medicine Combretastatin A4 analogs NANJING SANHOME PHARMACEUTICAL CO LTD 2013-08-28 — — CN disclosed
Send feedback